What is eXoZymes, Inc.?
operates as a development stage biotechnology company.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 27.42M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 13,729 shares $19k | 5855 shares $6k |
| 3-6months | 0 | 0 |
| 6-9months | 21,500 shares $15k | 0 |
| 9-12months | 0 | 0 |